Trulieve Cannabis Corp. Subordinate Voting Shares (TRLV)
NYSE: TRLVHealth Care Medicinal Chemicals and Botanical Products USD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
After hours: 10.76 -0.21%
TRLV stock chart
Technical analysisKey statistics
All statistics- Market cap
- $2.08B
- Forward P/E
- 19.37
- EPS (TTM)
- -$2.43
- Dividend yield
- None
- 52-week range
- 4.62 – 13.28
- Day range
- 10.55 – 10.92
- Volume / Avg
- 2.01M / 1.58M
- Beta
- —
- Shares outstanding
- 170.16M
- Next earnings
- Nov 5, 2026
52-week range
TRLV stock today
Shares of Trulieve Cannabis Subordinate Voting Shares (TRLV) finished higher on Oct 7 at $10.78, a gain of 1.22% or $0.13 per share, versus the S&P 500's 0.22% decline. At this level, TRLV sits in the middle of its 52-week range of $4.62 to $13.28: 18.8% below the high, set on Jun 9, 2026 and 133.5% above the low. TRLV is up 24.1% year to date, outperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has gained 21.3%.
Trulieve Cannabis Subordinate Voting Shares has posted a net loss over the last twelve months (EPS of -$2.43), so its P/E ratio is not meaningful. Trulieve Cannabis Subordinate Voting Shares's next earnings report is expected on Nov 5, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About Trulieve Cannabis Subordinate Voting Shares
Company profileTrulieve Cannabis Corp. operates as a cannabis retailer in the United States. The company cultivates, processes, and manufactures cannabis products and distributes its products to its dispensaries, as well as through home delivery.
- Sector
- Health Care
- Industry
- Medicinal Chemicals and Botanical Products
- CEO
- Ms. Kimberly Rivers J.D.
- Headquarters
- Tallahassee, FL
- Employees
- 5,000
- Website
- trulieve.com
Analyst forecast
ForecastConsensus (7 analysts)
strong_buy
Avg. price target
$18.18+68.65%
- Strong buy 1
- Buy 6
- Hold 0
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Next report
- Nov 5, 2026
- EPS estimate
- $0.09
Trulieve Cannabis Subordinate Voting Shares peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| CRONCronos Group Inc. | 3.24 | -1.37% | $1.19B | vs TRLV |
| TLRYTilray Brands Inc. | 3.72 | -1.72% | $549.01M | vs TRLV |
| GLASGlass House Brands Inc. Subordinate Voting Shares | 5.13 | -0.58% | $483.46M | vs TRLV |
| CGCCanopy Growth Corporation | 0.8765 | -1.59% | $393.81M | vs TRLV |
| OBIOOrchestra BioMed Holdings Inc. | 5.66 | -3.08% | $340.19M | vs TRLV |
| SNDLSNDL Inc. | 1.25 | +1.63% | $307.65M | vs TRLV |
| ACBAurora Cannabis Inc. | 4.46 | -2.83% | $282.36M | vs TRLV |
| USNAUSANA Health Sciences Inc. | 14.67 | -1.08% | $271.05M | vs TRLV |
Indexes, lists and sector
Trulieve Cannabis Subordinate Voting Shares stock FAQ
What is Trulieve Cannabis Subordinate Voting Shares's stock price today?
TRLV last traded at $10.78 as of Oct 7, 4:00 PM EDT, up 1.22% on the day. Prices are delayed at least 15 minutes.
When is Trulieve Cannabis Subordinate Voting Shares's next earnings date?
Trulieve Cannabis Subordinate Voting Shares is expected to report earnings on Thursday, November 5, 2026. Analysts expect EPS of $0.09.
Who is Trulieve Cannabis Subordinate Voting Shares's CEO?
Ms. Kimberly Rivers J.D. is the chief executive officer of Trulieve Cannabis Corp. Subordinate Voting Shares, which has about 5,000 employees.
What is the TRLV 52-week high?
The 52-week high for TRLV is $13.28 and the 52-week low is $4.62. The stock is currently 18.8% below its high.